WELCOME TO The PHARMACEUTICAL REPORT
Home > News >
Trending news >
Newron Pharma Delays Schizophrenia Trials Over Safety Concerns
biospace | May 28, 2019
In this 1-minute video Dr Sarah Sowden explains: Common mental disorders (CMDs) can relate to poverty, Non-pharmaceutical interventions for CMDs were reviewed, Study found positive effects of non-pharmaceutical interventions
Dom Nicastro | April 03, 2020
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE